... despite these informations, I still prefer "structure factor amplitude", because it is the amplitude of the "structure factor" ...

Best regards,

Dirk.

Am 12.01.2009 um 11:42 schrieb Ian Tickle:

I was taught 'structure amplitude' - makes perfect sense to me!  Why
does 'structure amplitude' make any less sense than 'structure factor'?

It also clearly made sense to Phil Coppens, a crystallographer of
considerable repute, see ITC Vol. B (2nd Ed.), sect 1.2., p.10: 'The
Structure Factor'.  To quote the introduction to the section: "The
'structure factor' is the central concept in structure analysis by
diffraction methods. Its modulus is called the 'structure amplitude'".

Also I did a 'Google vote' for the two terms. 'Structure amplitude' has 11300 hits. 'Structure factor amplitude' has only 4750. So all round I
would say that 'structure amplitude' wins by a considerable margin.

Cheers

-- Ian

-----Original Message-----
From: owner-ccp...@jiscmail.ac.uk
[mailto:owner-ccp...@jiscmail.ac.uk] On Behalf Of Pavel Afonine
Sent: 11 January 2009 03:01
To: Ethan A Merritt
Cc: CCP4BB@jiscmail.ac.uk
Subject: Re: [ccp4bb] structure (factor) amplitude



On 1/10/2009 5:14 PM, Ethan A Merritt wrote:

        On Saturday 10 January 2009, Bernhard Rupp wrote:
        

                Dear All,
                
                I am getting conflicting comments on the use of
                'structure factor amplitude'
                vs. just
                'structure amplitude'
                for |F|.
                

        
        ???
        That's just... odd.
        
        |F| is the amplitude of F.
        But no way F is a "structure".
        


I agree. If F is a structure factor then |F| is a structure
factor amplitude. "structure amplitude" doesn't make much sense...
Pavel.


Disclaimer
This communication is confidential and may contain privileged information intended solely for the named addressee(s). It may not be used or disclosed except for the purpose for which it has been sent. If you are not the intended recipient you must not review, use, disclose, copy, distribute or take any action in reliance upon it. If you have received this communication in error, please notify Astex Therapeutics Ltd by emailing i.tic...@astex-therapeutics.com and destroy all copies of the message and any attached documents. Astex Therapeutics Ltd monitors, controls and protects all its messaging traffic in compliance with its corporate email policy. The Company accepts no liability or responsibility for any onward transmission or use of emails and attachments having left the Astex Therapeutics domain. Unless expressly stated, opinions in this message are those of the individual sender and not of Astex Therapeutics Ltd. The recipient should check this email and any attachments for the presence of computer viruses. Astex Therapeutics Ltd accepts no liability for damage caused by any virus transmitted by this email. E-mail is susceptible to data corruption, interception, unauthorized amendment, and tampering, Astex Therapeutics Ltd only send and receive e-mails on the basis that the Company is not liable for any such alteration or any consequences thereof. Astex Therapeutics Ltd., Registered in England at 436 Cambridge Science Park, Cambridge CB4 0QA under number 3751674


*******************************************************
Dirk Kostrewa
Gene Center, A 5.07
Ludwig-Maximilians-University
Feodor-Lynen-Str. 25
81377 Munich
Germany
Phone:  +49-89-2180-76845
Fax:    +49-89-2180-76999
E-mail: kostr...@lmb.uni-muenchen.de
*******************************************************

Reply via email to